These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17682206)

  • 1. [Dynamic enhanced MRI and chemosensitivity in breast cancer].
    Nagashima T; Sakakibara M; Miyazaki M; Kazama T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():530-4. PubMed ID: 17682206
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
    Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
    Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MR imaging in the management of patients with breast cancer].
    Yuen S; Goto M; Nishimura T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():357-62. PubMed ID: 17679208
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool?
    Lorenzon M; Zuiani C; Londero V; Linda A; Furlan A; Bazzocchi M
    Eur J Radiol; 2009 Jul; 71(1):82-8. PubMed ID: 18472240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer].
    Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH
    Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.
    Knopp MV; Brix G; Junkermann HJ; Sinn HP
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic optical breast imaging: a new technique to visualise breast vessels: comparison with breast MRI and preliminary results.
    Athanasiou A; Vanel D; Balleyguier C; Fournier L; Mathieu MC; Delaloge S; Dromain C
    Eur J Radiol; 2005 Apr; 54(1):72-9. PubMed ID: 15797295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI in the detection and management of breast cancer.
    Padhani AR; Ah-See ML; Makris A
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):239-52. PubMed ID: 15877522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of contrast-enhanced breast MR imaging.
    Piccoli CW
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):557-71. PubMed ID: 7489308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of enhancement patterns using three-dimensional dynamic contrast-enhanced MR imaging in 209 cases of breast cancer].
    Kuwada T; Tozaki M; Harada J
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Nov; 64(8):544-51. PubMed ID: 15651359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of the aggressiveness of breast cancer by MRI].
    Kimijima I
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():367-72. PubMed ID: 17682180
    [No Abstract]   [Full Text] [Related]  

  • 13. [MRI features of space-occupying lesions in the breast].
    Serebriakova SV; Trufanov GE; Fokin VA; Iukhno EA; Tikhova KE; Iakovleva EK
    Vopr Onkol; 2011; 57(1):92-8. PubMed ID: 21598716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research for breast cancer patients. Progress on a broad front (interview by Dr. med. Jochen Aumiller)].
    Janni W
    MMW Fortschr Med; 2009 Jan; 151(1-2):15-6. PubMed ID: 19227632
    [No Abstract]   [Full Text] [Related]  

  • 15. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
    Ghanouni P; Kurian AW; Margolis D; Hartman AR; Mills MA; Plevritis SK; Ford JM; Daniel BL
    Breast J; 2007; 13(3):281-6. PubMed ID: 17461903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases from breast cancer.
    Seidman AD
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):595-7. PubMed ID: 21157408
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI.
    Gibbs P; Liney GP; Lowry M; Kneeshaw PJ; Turnbull LW
    Breast; 2004 Apr; 13(2):115-21. PubMed ID: 15019691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typical atypical findings on dynamic MRI of the breast.
    Kurz KD; Roy S; Mödder U; Skaane P; Saleh A
    Eur J Radiol; 2010 Nov; 76(2):195-210. PubMed ID: 19726148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.